Compare
Senseonics Holdings, Inc. vs Radnostix Inc vs Mesa Laboratories Inc vs Ralliant Corp
| Latest fiscal year | Senseonics Holdings, Inc. SENS | Radnostix Inc INIS | Mesa Laboratories Inc MLAB | Ralliant Corp RAL |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-03-31 | 2025-12-31 |
| Revenue | $35.26M | $13.07M | $249.13M | $2.07B |
| Revenue growth (YoY) | +56.9% | -6.0% | +3.4% | -4.0% |
| Gross margin | 44.7% | 58.9% | 63.5% | 50.3% |
| Operating margin | -193.8% | -7.3% | 7.4% | -57.2% |
| Net margin | -196.0% | -6.9% | 2.7% | -59.1% |
| Net income | -$69.11M | -$908.0K | $6.71M | -$1.22B |
| EPS (Diluted) | -$1.66 | $0.00 | $1.21 | -$10.84 |
| Operating cash flow | -$59.13M | $620.2K | $42.83M | $397.60M |
| Free cash flow | -$60.24M | $86.0K | $39.58M | $358.40M |
| Cash & equivalents | $40.23M | $1.70M | $26.93M | $318.80M |
| Total assets | $126.27M | $17.84M | $427.75M | $3.82B |
| Total liabilities | $65.22M | $14.14M | $241.50M | $2.19B |
| Shareholders' equity | $61.05M | $3.69M | $186.25M | $1.63B |
| Return on year-end equity | -113.2% | -24.6% | 3.6% | -74.8% |
| Shares outstanding | 41.27M | 528.21M | 5.52M | 112.90M |
Revenue, most recent five fiscal years
| Fiscal year | Senseonics Holdings, Inc. | Radnostix Inc | Mesa Laboratories Inc | Ralliant Corp |
|---|---|---|---|---|
| Latest | $35.26M Ended 2025-12-31 | $13.07M Ended 2025-12-31 | $249.13M Ended 2026-03-31 | $2.07B Ended 2025-12-31 |
| 1 year earlier | $22.47M Ended 2024-12-31 | $13.90M Ended 2024-12-31 | $240.98M Ended 2025-03-31 | $2.15B Ended 2024-12-31 |
| 2 years earlier | $22.39M Ended 2023-12-31 | $12.27M Ended 2023-12-31 | $216.19M Ended 2024-03-31 | $2.16B Ended 2023-12-31 |
| 3 years earlier | $16.39M Ended 2022-12-31 | $11.18M Ended 2022-12-31 | $219.08M Ended 2023-03-31 | n/a |
| 4 years earlier | $13.68M Ended 2021-12-31 | $9.66M Ended 2021-12-31 | $184.34M Ended 2022-03-31 | n/a |